ATE526400T1 - Metalloproteaseproteine - Google Patents
MetalloproteaseproteineInfo
- Publication number
- ATE526400T1 ATE526400T1 AT03782702T AT03782702T ATE526400T1 AT E526400 T1 ATE526400 T1 AT E526400T1 AT 03782702 T AT03782702 T AT 03782702T AT 03782702 T AT03782702 T AT 03782702T AT E526400 T1 ATE526400 T1 AT E526400T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- metalloprotease
- metalloprotease proteins
- insp005b
- insp005a
- Prior art date
Links
- 102000005741 Metalloproteases Human genes 0.000 title abstract 2
- 108010006035 Metalloproteases Proteins 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0230006.9A GB0230006D0 (en) | 2002-12-23 | 2002-12-23 | Proteins |
| PCT/GB2003/005664 WO2004056983A2 (en) | 2002-12-23 | 2003-12-23 | Metalloprotease proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526400T1 true ATE526400T1 (de) | 2011-10-15 |
Family
ID=9950313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03782702T ATE526400T1 (de) | 2002-12-23 | 2003-12-23 | Metalloproteaseproteine |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7557079B2 (enExample) |
| EP (1) | EP1583825B1 (enExample) |
| JP (1) | JP5053516B2 (enExample) |
| AT (1) | ATE526400T1 (enExample) |
| AU (1) | AU2003290342B2 (enExample) |
| CA (1) | CA2510066A1 (enExample) |
| ES (1) | ES2374392T3 (enExample) |
| GB (1) | GB0230006D0 (enExample) |
| IL (1) | IL169256A (enExample) |
| NO (1) | NO20053575L (enExample) |
| WO (1) | WO2004056983A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100183617A1 (en) * | 2005-02-23 | 2010-07-22 | University Of Virginia Patent Foundation | Compositions and methods for regulating sas1r |
| GB0921001D0 (en) | 2009-11-30 | 2010-01-13 | Aqua Bio Technology Asa | Products and uses |
| CN109957557B (zh) * | 2017-12-26 | 2023-01-06 | 广州市锐博生物科技有限公司 | Dna聚合酶及其制备方法 |
| CN114032252B (zh) * | 2021-11-01 | 2022-04-22 | 武汉爱博泰克生物科技有限公司 | 一种重组状态人源mmp-7蛋白的表达方法及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166902A1 (en) * | 2001-02-20 | 2003-09-04 | Yi Hu | Novel human protease and polynucleotides encoding the same |
| JP2004508021A (ja) | 2000-08-23 | 2004-03-18 | アプレラ コーポレーション | 単離ヒトプロテアーゼタンパク質、ヒトプロテアーゼタンパク質をコード化する核酸分子及びその使用 |
| CA2459140A1 (en) | 2001-09-14 | 2003-03-27 | Incyte Genomics, Inc. | Protein modification and maintenance molecules |
-
2002
- 2002-12-23 GB GBGB0230006.9A patent/GB0230006D0/en not_active Ceased
-
2003
- 2003-12-23 CA CA002510066A patent/CA2510066A1/en not_active Abandoned
- 2003-12-23 WO PCT/GB2003/005664 patent/WO2004056983A2/en not_active Ceased
- 2003-12-23 EP EP03782702A patent/EP1583825B1/en not_active Expired - Lifetime
- 2003-12-23 AU AU2003290342A patent/AU2003290342B2/en not_active Ceased
- 2003-12-23 JP JP2004561689A patent/JP5053516B2/ja not_active Expired - Fee Related
- 2003-12-23 ES ES03782702T patent/ES2374392T3/es not_active Expired - Lifetime
- 2003-12-23 US US10/539,847 patent/US7557079B2/en not_active Expired - Fee Related
- 2003-12-23 AT AT03782702T patent/ATE526400T1/de not_active IP Right Cessation
-
2005
- 2005-06-17 IL IL169256A patent/IL169256A/en not_active IP Right Cessation
- 2005-07-21 NO NO20053575A patent/NO20053575L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2510066A1 (en) | 2004-07-08 |
| ES2374392T3 (es) | 2012-02-16 |
| EP1583825A2 (en) | 2005-10-12 |
| AU2003290342B2 (en) | 2009-09-24 |
| JP2006516888A (ja) | 2006-07-13 |
| WO2004056983A3 (en) | 2006-02-09 |
| JP5053516B2 (ja) | 2012-10-17 |
| GB0230006D0 (en) | 2003-01-29 |
| EP1583825B1 (en) | 2011-09-28 |
| US7557079B2 (en) | 2009-07-07 |
| US20060252117A1 (en) | 2006-11-09 |
| IL169256A0 (en) | 2007-07-04 |
| NO20053575L (no) | 2005-09-23 |
| IL169256A (en) | 2010-11-30 |
| NO20053575D0 (no) | 2005-07-21 |
| WO2004056983A2 (en) | 2004-07-08 |
| AU2003290342A1 (en) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003055912A3 (en) | Secreted proteins | |
| ATE482976T1 (de) | Defensinproteine | |
| WO2004096856A3 (en) | Secreted protein family | |
| ATE526400T1 (de) | Metalloproteaseproteine | |
| WO2006046073A3 (en) | C1q related protein | |
| WO2004053117A3 (en) | Serine protease | |
| ATE442382T1 (de) | Ein die mam-domäne enthaltendes protein | |
| UA93658C2 (en) | Cell surface glycoprotein | |
| MXPA05012414A (es) | Proteina secretada similar a tnf. | |
| WO2004101618A3 (en) | Progestin-yol002c-cgi-45 receptor-related proteins | |
| NO20052525D0 (no) | Spleisevariant av humant hypofyseveksthormon | |
| WO2003054178A3 (en) | Metalloprotease proteins | |
| WO2002033058A3 (en) | Novel cysteine proteases and uses thereof | |
| WO2004035626A3 (en) | Alpha macroglobulin protein family members | |
| WO2007049062A3 (en) | Vwfa-domain containing proteins | |
| WO2008001045A8 (en) | Members of the glycoside hydrolase family 31 family of proteins | |
| WO2004026905A3 (en) | Transporter/channel proteins | |
| WO2004000882A3 (en) | Proteins | |
| WO2002062976A3 (en) | Serine proteases | |
| WO2002062845A3 (en) | Adhesion molecules | |
| WO2003089469A3 (en) | Cation channel proteins | |
| WO2002044382A8 (en) | Cytokine-like proteins | |
| WO2004041861A3 (en) | Alpha macroglobulin family member | |
| WO2004011648A3 (en) | CYTOCHROME P450s | |
| WO2004024762A3 (en) | Il-8 like protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |